Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04961229
What this trial is testing

Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeImmunosuppression
dafna yahav 504
Very early researchUnknownNCT05928455
What this trial is testing

The Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001

Who this might be right for
COVID-19Vaccine Reaction
Guangzhou Patronus Biotech Co., Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT05016622
What this trial is testing

Booster Dose Trial

Who this might be right for
Cancer
Montefiore Medical Center 106
Testing effectiveness (Phase 2)Study completedNCT05305573
What this trial is testing

Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 26
Large-scale testing (Phase 3)Study completedNCT05381350
What this trial is testing

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 1,750
Large-scale testing (Phase 3)UnknownNCT05686161
What this trial is testing

MRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs

Who this might be right for
ImmunogenicitySafetyEfficacy
Stemirna Therapeutics 600
Large-scale testing (Phase 3)Study completedNCT05188677
What this trial is testing

Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty 1,831
Testing effectiveness (Phase 2)UnknownNCT04992182
What this trial is testing

Reactogenicity, Safety, and Immunogenicity of Covid-19 Vaccine Booster

Who this might be right for
Covid19
Universidad del Desarrollo 534
Large-scale testing (Phase 3)UnknownNCT05580159
What this trial is testing

New Generation mRNA Booster Vaccine Against Emerging VOCs

Who this might be right for
ImmunogenicityEfficacySafety
Stemirna Therapeutics 2,000
Large-scale testing (Phase 3)Study completedNCT05542862
What this trial is testing

Booster Study of SpikoGen COVID-19 Vaccine

Who this might be right for
COVID-19
Vaxine Pty Ltd 81
Testing effectiveness (Phase 2)Study completedNCT06234956
What this trial is testing

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

Who this might be right for
SARS CoV 2 Infection
Hipra Scientific, S.L.U 242
Not applicableWithdrawnNCT05539703
What this trial is testing

Trial of 2nd Booster Dose of COVID-19 Vaccine

Who this might be right for
COVID-19
Norwegian Institute of Public Health
Not applicableUnknownNCT05689177
What this trial is testing

Humoral Immunity Study After a Booster Dose of Soberana Plus (FINLAY-FR-1A) Vaccine Against COVID-19

Who this might be right for
Humoral Immunity
Gomel State Medical University 100
Large-scale testing (Phase 3)Study completedNCT04927065
What this trial is testing

Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 5,161
Testing effectiveness (Phase 2)UnknownNCT05239832
What this trial is testing

Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 34
Large-scale testing (Phase 3)Study completedNCT05517642
What this trial is testing

IH Convidecia as Second Booster Dose Against Breakthrough Infections

Who this might be right for
COVID-19
CanSino Biologics Inc. 540
Early research (Phase 1)Study completedNCT05541861
What this trial is testing

Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 383
Large-scale testing (Phase 3)WithdrawnNCT05156632
What this trial is testing

Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT04611802
What this trial is testing

Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 33,000
Early research (Phase 1)Study completedNCT05216601
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19

Who this might be right for
COVID-19 Vaccine
Medigen Vaccine Biologics Corp. 107
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation